Stephen F. Betz - Dec 31, 2024 Form 5 Insider Report for Crinetics Pharmaceuticals, Inc. (CRNX)

Role
Chief Scientific Officer
Signature
Marc Wilson, as attorney-in-fact
Stock symbol
CRNX
Transactions as of
Dec 31, 2024
Transactions value $
$6,756
Form type
5
Date filed
1/29/2025, 04:30 PM
Previous filing
Dec 18, 2024
Next filing
Feb 24, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRNX Common Stock Other $6.76K +451 +0.64% $14.98 71.4K Nov 20, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares purchased under Crinetics Pharmaceuticals, Inc. 2018 Employee Stock Purchase Plan in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c),